Search Results
Sep 03, 2026, 11:08 ET New Analysis: No Surprises Act Cuts Out-Of-Network Emergency Spending by as Much as 52%
insurer's initial payment or open negotiation, and claims decided through formal IDR. Because public payment data are not available for claims subject to the NSA and eligible for the IDR process, but resolved outside of IDR, the analysis evaluates three scenarios in which those claims are paid at the qualifying
More news about: HaloMD
Sep 02, 2026, 00:00 ET Chiraag Shah joins Crowell & Moring's International Dispute Resolution Practice in London
proven excellence as an arbitration practitioner and longstanding relationships across key arbitration markets, particularly Africa and MENA, with our IDR team's international presence, including in London, Doha, and Brussels, will enhance our ability to support clients in complex cross-border disputes
More news about: Crowell & Moring LLP
Sep 01, 2026, 11:03 ET HaloMD Welcomes Nationally Recognized Emergency Physician James Shoemaker Jr., MD, as Senior Vice President of Physician Experience and Advocacy
healthcare system where independent practices can thrive.About HaloMDHaloMD is the leading authority in Independent Dispute Resolution (IDR) under the No Surprises Act and state balance-billing laws. Powered by proprietary technology, advanced analytics and deep specialty expertise, HaloMD
More news about: HaloMD
Sep 01, 2026, 07:00 ET RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®
Burden of Clostridioides difficile Infections, 2016-2024: A Systematic Review and Meta-Analysis. Infect Dis Rep. 2025 Apr 14;17(2):31. doi: 10.3390/idr17020031. PMID: 40277958; PMCID: PMC12026862.[2] Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM,
More news about: RedHill Biopharma Ltd.
Aug 25, 2026, 05:30 ET Fifth Circuit Rejects "Ghost Rates" in Federal QPA Calculations Under the No Surprises Act
created significant hardship for providers such as Nutex Health. As a result, providers have often had to pursue the Independent Dispute Resolution (IDR) process simply to obtain fair median in-network rates, an approach that is time-consuming and costly for both insurers and providers. We hope this landmark
More news about: Nutex Health, Inc.
Aug 20, 2026, 10:31 ET Radiotherapy-Induced Oral Mucositis Market Set for Strong Growth Through 2036, Driven by Emerging Therapies and Rising Cancer Burden | DelveInsight
MIT-001 (MitoImmune Therapeutics), and others. Soligenix's Dusquetide (SGX942) is an investigational innate defense regulator (IDR) intended to treat oral mucositis, particularly radiotherapy-induced oral mucositis (RIOM) in patients receiving treatment for head and neck cancer.
More news about: DelveInsight Business Research, LLP
Aug 18, 2026, 06:02 ET Fitch Upgrades IIFL Finance to 'BB-'; Outlook Stable
Fitch Ratings has upgraded IIFL Finance (IIFL) Long-Term Issuer Default Rating (IDR) to 'BB-' from 'B+'. The Outlook is Stable. Fitch has also upgraded the senior secured debt and global medium-note programme (GMTN) ratings to 'BB-'
More news about: IIFL Finance Limited
Aug 12, 2026, 14:10 ET Fifth Circuit Cites Unlawfully Calculated QPAs as Key Driver of No Surprises Act Problems
Circuit just took away one of their tools to do it."About HaloMDHaloMD is the No. 1 provider of Independent Dispute Resolution (IDR) services as indicated by public CMS data, backed by industry-leading technology infrastructure and data intelligence. The company supports healthcare
More news about: HaloMD
Aug 10, 2026, 00:21 ET KUAISHOU GAMING WINS AT THE HONOR OF KINGS WORLD CUP AT ESPORTS WORLD CUP 2026 AS PACKED GLOBAL ESPORTS SEASON HITS FULL SWING
July to November at more than 16 secondary schools across Indonesia, attracting more than 2,400 participants and offering a total prize pool of over IDR 60 million.
More news about: Honor of Kings
Aug 07, 2026, 07:30 ET Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results
BioTherapeutics business segment is developing synthetic hypericin for the treatment of psoriasis (SGX302), and our first-in-class Innate Defense Regulator (IDR) technology, dusquetide, for the treatment of inflammatory diseases, including aphthous ulcers in Behçet's Disease (BD) (SGX945) and oral mucositis in
More news about: SOLIGENIX, INC.
Aug 06, 2026, 17:58 ET NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
compared to 2025 is due to the positive results from the early stage improvement in the IDR process that were realized in the first half of 2025.The Company has submitted between 50–60% of its claims through IDR; when an award determination is made, Nutex Health currently prevails in over 85% of those
More news about: Nutex Health, Inc.
Aug 03, 2026, 08:32 ET FAIR Health NSA and Allowed Data Products May Be Introduced in IDR Proceedings to Support Offers, and IDR Entities May Consult FAIR Health Data to Validate Party Submissions
consideration by certified independent dispute resolution entities (IDREs) in the federal NSA IDR process; IDREs may also consult FAIR Health data to validate such submissions. Find out more about the federal NSA IDR process
More news about: FAIR Health
Jul 13, 2026, 20:00 ET Georgia Federal Court Dismisses Lawsuit Against HaloMD, Delivering Third Consecutive Victory Over Insurer Lawfare Campaign
Court notes that the Plaintiff argues that it loses a lot of IDR arbitrations. For example, it says that of the 228 IDRs the Defendants initiated on May 3, 2024, the Plaintiff lost 192. It cites CMS data that Providers prevailed in 85% of IDR payment determinations. It is highly improbable to infer from
More news about: HaloMD
Jun 30, 2026, 05:03 ET IDX Advances Market Transparency Frameworks to Solidify Investor Confidence
investors contributing 52.5% of daily trading value. Net subscriptions into equity mutual funds reached IDR21.98 trillion (USD 1.35 billion) as of April 20, substantially exceeding the same period in 2025 (IDR6.27 trillion).Advancing Free Float Reform A core pillar of the agenda remains the
More news about: Indonesia Stock Exchange (IDX)
Jun 30, 2026, 04:55 ET IDX Advances Market Transparency Frameworks to Solidify Investor Confidence
investors contributing 52.5% of daily trading value. Net subscriptions into equity mutual funds reached IDR21.98 trillion (USD 1.35 billion) as of April 20, substantially exceeding the same period in 2025 (IDR6.27 trillion).Advancing Free Float Reform A core pillar of the agenda remains the
More news about: Indonesia Stock Exchange (IDX)
Jun 22, 2026, 04:23 ET The Search For India's Next Breakthrough Innovations Begins As Marico Innovation Foundation Invites Applications For Indian Innovation Icons 2027
ATE Capital, will comprise Deepali Khanna, Senior Vice President and Head of Asia, The Rockefeller Foundation; Samarinita Shetty, Co-founder and CEO, IDR; Chetna Gala Sinha, Founder and Chairperson, Mann Deshi Bank and Mann Deshi Foundation; Aniket Doegar, CEO, Haqdarshak; Prateek Madhav, CEO and Co-founder,
More news about: Marico Innovation Foundation
Jun 08, 2026, 07:30 ET Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
BioTherapeutics business segment is developing synthetic hypericin for the treatment of psoriasis (SGX302), and our first-in-class Innate Defense Regulator (IDR) technology, dusquetide, for the treatment of inflammatory diseases, including aphthous ulcers in Behçet's Disease (BD) (SGX945) and oral mucositis in
More news about: SOLIGENIX, INC.
May 29, 2026, 14:14 ET HaloMD Commends CMS for Finalizing IDR, Urges Congress to Pass Enforcement Legislation to Close Remaining Loopholes in NSA Framework
2026 /PRNewswire/ -- HaloMD welcomed the Centers for Medicare & Medicaid Services' (CMS) final rule modernizing the Independent Dispute Resolution (IDR) process established under the No Surprises Act (NSA), calling it a major step toward creating a more efficient arbitration system for providers, payers
More news about: HaloMD
May 28, 2026, 12:39 ET /C O R R E C T I O N -- HaloMD/
Dispute Resolution (IDR). In response to BCBS Texas's attempted end-run around the arbitration process, the Court found that, "…the collateral attack doctrine is even more clearly applicable where, as here, Plaintiff is attempting to relitigate issues previously decided by the IDR entities…". The same
More news about: HaloMD
May 26, 2026, 07:30 ET Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
BioTherapeutics business segment is developing synthetic hypericin for the treatment of psoriasis (SGX302), and our first-in-class Innate Defense Regulator (IDR) technology, dusquetide, for the treatment of inflammatory diseases, including aphthous ulcers in Behçet's Disease (BD) (SGX945) and oral mucositis in
More news about: SOLIGENIX, INC.
May 20, 2026, 14:20 ET HaloMD Earns 2026 Great Place To Work Certification™, With 89% of Employees Confirming It's a Great Place to Work
DALLAS, May 20, 2026 /PRNewswire/ -- HaloMD, an industry-leading provider of Independent Dispute Resolution (IDR) services under the No Surprises Act and State Balance Billing Laws, today announced it has been Certified™ by Great Place To Work®. The recognition
More news about: HaloMD
May 08, 2026, 07:30 ET Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
BioTherapeutics business segment is developing synthetic hypericin for the treatment of psoriasis (SGX302), and our first-in-class Innate Defense Regulator (IDR) technology, dusquetide, for the treatment of inflammatory diseases, including aphthous ulcers in Behçet's Disease (BD) (SGX945) and oral mucositis in
More news about: SOLIGENIX, INC.
May 04, 2026, 11:45 ET Tungsten Reshoring Goes Public: Western Star Files DIBC Application as APT Prices Surge ~900% YoY and the U.S. Defense Procurement Cliff Closes In
Inc. (CSE: WSR) (OTC: WSRIF), IperionX Limited (NASDAQ: IPX), Lynas Rare Earths Ltd. (OTCQX: LYSDY), Idaho Strategic Resources, Inc. (NYSE American: IDR), Trilogy Metals Inc. (NYSE American: TMQ)Key Takeaways:Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF)
More news about: Equity Insider
Apr 30, 2026, 17:15 ET NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
continued to be supported by higher acuity claims and favorable outcomes in the Independent Dispute Resolution ("IDR") process. The Company has submitted between 50–60% of its claims through IDR; when an award determination is made, Nutex Health currently prevails in over 85% of those determinations and
More news about: Nutex Health, Inc.
Apr 29, 2026, 17:55 ET Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm
(ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (iii) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material
More news about: Kuehn Law, PLLC